A Prospective Clinical Study On A Total Hip Resurfacing System

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00603395

Enrollment

298

Registered

2008-01-29

Start date

2004-09-30

Completion date

2014-05-31

Last updated

2014-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis, Avascular Necrosis

Brief summary

This prospective clinical study is to demonstrate the efficacy and safety of ReCap Total Hip Resurfacing System.

Interventions

DEVICEReCap Total Hip Resurfacing System

This is a hip resurfacing system.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* intended for skeletally mature individuals undergoing primary surgery as a result of hip degenerative joint disease, or any composite diagnoses, including: * Osteoarthritis * Avascular necrosis * Traumatic arthritis * Legg Perthes * Rheumatoid arthritis

Design outcomes

Primary

Measure	Time frame
Harris Hip Score, Device Revision/Removal, Radiographic Evaluation	2 years postoperative

Secondary

Measure	Time frame
Complications	Anytime

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026